Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
22 May 2012
Case demonstrates Coloplast’s commitment to defend Intellectual Property rights now and in the future
May 8, 2012— Coloplast North America today announced that a federal court jury in Tacoma, Wash., ruled that Generic Medical Devices, Inc. (GMD) was infringing on a Coloplast Urology Care patent for the transobturator (TOT) method for treating stress urinary incontinence in women. Using this approach, surgeons implant Coloplast’s Aris® sling to help women regain control of their bladder.
The jury found that GMD infringed six separate claims of U.S. Patent Number 7,621,864, by marketing and selling its surgical tools and sling products for the purpose of using the TOT surgical method patented by Coloplast. The court soon will schedule a briefing on Coloplast’s motion for a permanent injunction.
“By pursuing and winning this patent case, Coloplast is able to protect the research and development investments we make,” said Steffen Hovard, senior vice president of Coloplast Urology Care. “Our mission is to improve patient quality of life. Protecting our patents allows us to realize that mission and push the industry forward through innovation. This is how we bring the best technologies, best devices and best methods to our surgeon partners and patients.”
Coloplast was represented in the patent case by Faegre Baker Daniels LLP.
About Aris®
Available upon request
This press release is more than three weeks old. We remove all product-related press releases after three weeks in order to comply with applicable regulation, but it’s still available upon request. Please reach out to our team for more information.